Pharmaceutical & Bioscience Society International is a 501(c)(3) organization based in San Mateo, California, registered in 2010, with $720,000 in FY2023 revenue. CharityIndex grades it B.
Revenue (FY2023)
$720K
▲ 164.6% vs prior year
Expenses (FY2023)
$540K
Net assets
$679K
Employees
—
Rated on 2 of 4 criteria — the rest aren't reported in this filing type.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for Pharmaceutical & Bioscience Society International— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Pharmaceutical & Bioscience Society International: 15 mo reserves · +25% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for Pharmaceutical & Bioscience Society International— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Pharmaceutical & Bioscience Society International: 2 of 5 disclosure signals earns a C on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue grew from $279K (FY2013) to $720K (FY2023) across 11 reported years.
Financial snapshot
Operating margin
25.0%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$679K
Total liabilities
$0
Net assets
$679K
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $720,000▲165% | $539,658▲379% | $679,098▲36.2% | $679,098▲36.2% | 990 |
| 2022 | $272,121▲4377% | $112,776▲58.3% | $498,756▲46.9% | $498,756▲46.9% | 990 |
| 2021 | $6,078▼71.0% | $71,250▲1.1% | $339,411▼16.1% | $339,411▼16.1% | 990 |
| 2020 | $20,930▼90.9% | $70,497▼72.0% | $404,583▼10.9% | $404,583▼10.9% | 990 |
| 2019 | $231,085▼25.5% | $251,555▼7.3% | $454,150▼4.3% | $454,150▼4.3% | 990 |
| 2018 | $310,103▼11.6% | $271,497▲2.2% | $474,620▲13.8% | $474,620▲13.8% | 990 |
| 2017 | $350,727▲15.6% | $265,723▲20.0% | $417,240▲25.6% | $417,240▲25.6% | 990 |
| 2016 | $303,349▲3.8% | $221,348▼12.7% | $332,236▲32.8% | $332,236▲32.8% | 990 |
| 2015 | $292,232▲9.5% | $253,504▲5.3% | $250,233▲18.3% | $250,233▲18.3% | 990 |
| 2014 | $266,897▼4.4% | $240,835▼5.3% | $211,505▲14.1% | $211,505▲14.1% | 990 |
| 2013 | $279,130 | $254,203▼42.3% | $185,443▲27.4% | $185,443▲27.4% | 990 |
| 2012 | — | $440,920▲60.1% | $145,548▼16.7% | $145,548▼16.7% | 990 |
| 2011 | — | $275,468▲20.4% | $174,721▲4.9% | $174,721▲4.9% | 990 |
| 2010 | — | $228,789 | $166,558 | $166,558 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Explore more
Data for Pharmaceutical & Bioscience Society International (EIN 61-1640566) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.